delivering robust financials

We believe that execution is everything
and always challenge ourselves to deliver superior performance

Investors

/Investors

Investors

Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.

Shareholder Information

  • Shareholder Structure
  • Share Performance
  • Financial Highlights

Learn More

Results, Reports & Presentations

  • Results Announcements
  • Financials – Excel Sheet Downloads
  • Disclosure of Events or Information

Learn More